1. Home
  2. Analysis
  3. Rhubarb
  4. Maxalt

Rhubarb and Maxalt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rhubarb and Maxalt. Common interactions include chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people who take Rhubarb and Maxalt have. It is created by eHealthMe based on reports of 6 people who take Rhubarb and Maxalt from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 13, 2022

6 people who take Rhubarb and Maxalt together, and have interactions are studied.

What is Rhubarb?

Rhubarb has active ingredients of rhubarb. eHealthMe is studying from 171 Rhubarb users for its effectiveness, alternative drugs and more.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 11,447 Maxalt users for its effectiveness, alternative drugs and more.

Number of Rhubarb and Maxalt reports submitted per year:

Rhubarb and Maxalt drug interactions.

Common Rhubarb and Maxalt drug interactions by gender *:

female:

n/a

male:

  1. Chronic obstructive pulmonary disease
  2. Decreased appetite
  3. Red blood cell count decreased
  4. Rhinitis allergic
  5. Skin ulcer
  6. Tremor
  7. Vocal cord polyp
  8. Psoriasis
  9. Gastritis erosive
  10. Immunosuppressant drug level increased

Common Rhubarb and Maxalt drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic obstructive pulmonary disease
  2. Decreased appetite
  3. Red blood cell count decreased
  4. Rhinitis allergic
  5. Skin ulcer
  6. Tremor
  7. Vocal cord polyp
  8. Psoriasis
  9. Gastritis erosive
  10. Immunosuppressant drug level increased

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Rhubarb and Maxalt?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Rhubarb and Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Maxalt side effects:

Browse all side effects of Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Maxalt interactions:

Browse all interactions between Maxalt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rhubarb and rizatriptan benzoate (the active ingredients of Rhubarb and Maxalt, respectively), and Rhubarb and Maxalt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Rhubarb and Maxalt.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.